| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 03/01/2007 | WO2004081032A3 Novel litaf binding site peptides and methods of using the same |
| 03/01/2007 | WO2004011617A3 Identification of a novel bitter taste receptor, t2r76 |
| 03/01/2007 | WO2003086277A3 Attenuated gram negative bacteria |
| 03/01/2007 | US20070050869 Regulatory sequences useful for production of plants with modified embryo and/or endosperm development |
| 03/01/2007 | US20070050868 Agents for phytoremediation |
| 03/01/2007 | US20070050866 Control of hypocotyllength and flowering time by COL8 gene |
| 03/01/2007 | US20070050865 Polynucleotide encoding 2-hydorxyisoflavanone dehydratase and application of the same |
| 03/01/2007 | US20070050864 Rubisco activase with increased thermostability and methods of use thereof |
| 03/01/2007 | US20070050860 Expressed Sequence Tags (ESTs) isolated from the Western Corn Rootworm; transgenic plant |
| 03/01/2007 | US20070050146 comprising a sequence of a pri-miRNA, pre-miRNA, miRNA, miRNA*, anti-miRNA, or a miRNA binding site; used to identify modulators of prostate and lung cancer |
| 03/01/2007 | US20070049745 Oligonucleotide synthesis using periodate salts |
| 03/01/2007 | US20070049744 Glucosyltransferases |
| 03/01/2007 | US20070049743 Novel nucleic acids and polypeptides |
| 03/01/2007 | US20070049741 For condensing DNA; ion exchanging |
| 03/01/2007 | US20070049740 Mammalian transforming growth factor beta-9 |
| 03/01/2007 | US20070049738 amino acid sequences covalent attached to retroviruses or to leukemia virus transmembrane glycoproteins; phage display libraries; drug targets |
| 03/01/2007 | US20070049736 Cytokine receptor specific immunoglobulin for prevention and treatment of infection, cell proliferative and autoimmune disorders |
| 03/01/2007 | US20070049730 for treatment of disorders which are mediated at least in part by Hedgehog (Hh) especially Desert hedgehog (Dhh) in particular testicular cancer |
| 03/01/2007 | US20070049728 Solid phase synthesis supports and methods |
| 03/01/2007 | US20070049550 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies |
| 03/01/2007 | US20070049546 Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals |
| 03/01/2007 | US20070049545 Antisense modulation of fibroblast growth factor receptor 3 expression |
| 03/01/2007 | US20070049544 Antisense IAP nucleobase oligomers and uses thereof |
| 03/01/2007 | US20070049543 Controlling gene expression; enzyme inhibitors |
| 03/01/2007 | US20070049542 exposing the bacterial cells to a growth-inhibiting amount of an antisense oligonucleotide compound, composed of morpholino subunits and phosphorus-containing intersubunit linkages joining a morpholino nitrogen of one subunit to a 5' exocyclic carbon of an adjacent subunit; Escherichia coli, Salmonella |
| 03/01/2007 | US20070049541 Administering oligonucleotide containing optimal nucleotide binding site for the transcription factor for therapy of disease associated with hyper-activated signal transduction pathways, particularly malignancy |
| 03/01/2007 | US20070049540 Oligonucleotide inhibiting the expression of star-binding protein (sbp) gene and method therefor |
| 03/01/2007 | US20070049530 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070049527 Nucleotide sequences coding cytokine receptor for identifying modulators for treating blood disorders associated with cancer treatment |
| 03/01/2007 | US20070049525 Soluble zcytor21, anti-zcytor21 antibodies and binding partners and methods of using in inflammation |
| 03/01/2007 | US20070048854 Obtained from Campylobacter species; for use in synthesis of lipooligosaccharide (LOS); ganglioside biosynthesis and mimetics for treatment of nervous system disorders |
| 03/01/2007 | US20070048847 Methods of producing antibodies to cytokine receptor |
| 03/01/2007 | US20070048845 Cytokine zalpha11 ligand fusion proteins |
| 03/01/2007 | US20070048844 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 03/01/2007 | US20070048843 Homogeneous preparations of IL-28 and IL-29 |
| 03/01/2007 | US20070048842 using an E. coli expression system for the large scale production of IL-21 to a level of greater than 1 g/L in fed batch fermentation |
| 03/01/2007 | US20070048841 Viricidal polypeptide for prevention and treatment of hepatitis infection |
| 03/01/2007 | US20070048839 Novel amylolytic enzyme extracted from bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
| 03/01/2007 | US20070048838 Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method |
| 03/01/2007 | US20070048837 Site specific protein modification |
| 03/01/2007 | US20070048836 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 03/01/2007 | US20070048835 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048834 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048833 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048832 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048831 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048830 Polynucleotide that encodes a protein composed of a first polypeptide disulfide-bonded to a second polypeptide that stimulates proliferation, differentiation, or migration of mesenchymal cells; monoclonal and single-chain antibodies; activating a cell-surface platelet-derived growth factor receptor |
| 03/01/2007 | US20070048829 polynucleotide that encode polypeptides having mitogenic activity on human aortic smooth muscle cells |
| 03/01/2007 | US20070048828 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders; used to stimulate the production of bone and/or connective tissue in both humans and non-human animals |
| 03/01/2007 | US20070048827 Mammalian transforming growth factor beta-9 |
| 03/01/2007 | US20070048826 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
| 03/01/2007 | US20070048825 Compositions and methods for the diagnosis and treatment of tumor |
| 03/01/2007 | US20070048824 Interleukin-17 receptor homologue |
| 03/01/2007 | US20070048823 Compositions and Methods for Producing Apolipoprotein Gene Products in Lactic Acid Bacteria |
| 03/01/2007 | US20070048822 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3 |
| 03/01/2007 | US20070048818 Human secreted proteins |
| 03/01/2007 | US20070048817 Synthesiing a cyclic dipeptide (Albonoursin) by transforming a host cell with a vector having a specific sequence and incubating to allow expression of a cyclodipeptide synthase that subsequently catalizes the cyclization of two amino acids |
| 03/01/2007 | US20070048810 ATP-binding cassette protein responsible for cytotoxin resistance |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048784 Novel human hydrolase family members and uses thereof |
| 03/01/2007 | US20070048781 Mammalian cytokines; related reagents and methods |
| 03/01/2007 | US20070048772 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/01/2007 | US20070048771 Nucleic acid of given sequence; useful as modulating agents in regulating cellular processes |
| 03/01/2007 | US20070048763 detection of certain polymorphism in the promoter region of the MIF gene to determine the risk, detect, diagnose, or prognosticate prostate cancer; |
| 03/01/2007 | US20070048759 Detection of target molecules with labeled nucleic acid detection molecules |
| 03/01/2007 | US20070048754 Epidermal growth factor receptor mutations |
| 03/01/2007 | US20070048753 Sodium channel protein type III alpha-subunit splice variant |
| 03/01/2007 | US20070048751 Method of diagnosing type II diabetes mellitus using multilocus marker, polynucleotide including marker associated with type II diabetes mellitus, and microarray and diagnostic kit including the polynucleotide |
| 03/01/2007 | US20070048748 Mutant polymerases for sequencing and genotyping |
| 03/01/2007 | US20070048740 Full-length cDNA |
| 03/01/2007 | US20070048736 Hepatitis |
| 03/01/2007 | US20070048330 Optimized multi-epitope constructs and uses thereof |
| 03/01/2007 | US20070048329 Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor |
| 03/01/2007 | US20070048322 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 03/01/2007 | US20070048309 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048308 Nucleic acid encoding cytokine receptor zcytor17 |
| 03/01/2007 | US20070048307 Nucleotide sequences coding cytokine receptor for identifying modulators for treating blood disorders associated with cancer treatment |
| 03/01/2007 | US20070048302 Interleukin-2 (IL-2); treating metastatic cancer, autoimmune disorders, and viral infections such as HIV by administering a peptide that peptide binds to the IL-2 beta chain |
| 03/01/2007 | US20070048301 Compositions and methods for the treatment of immune related diseases |
| 03/01/2007 | US20070048300 Antibodies having altered effector function and methods for making the same |
| 03/01/2007 | US20070048299 Methods of inducing an immune response |
| 03/01/2007 | US20070048297 Human secreted proteins |
| 03/01/2007 | US20070048294 Method for inhibiting telomerase activity |
| 03/01/2007 | US20070048293 Manipulation of PTEN in T cells as a strategy to modulate immune responses |
| 03/01/2007 | US20070048286 Method of treating dopaminergic and GABA-nergic disorders |
| 03/01/2007 | US20070048283 Exposing to immunogenic portion of protein and/or encoding nucleotide homologenous to sequence 20 or 22b; eliciting response to 74P3B3 protein; pancreatic cancer |
| 03/01/2007 | US20070048256 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders |
| 03/01/2007 | DE102005040259A1 Verfahren zur Gewinnung von Nukleinsäuren aus Blut A process for recovering nucleic acids from blood |
| 03/01/2007 | CA2619105A1 Methods and kits for sense rna synthesis |
| 03/01/2007 | CA2615560A1 Compositions and methods to control angiogenesis with cupredoxins |
| 03/01/2007 | CA2583501A1 Enhanced zein reduction in transgenic corn seed |
| 02/28/2007 | EP1757695A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757694A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1756317A2 Methods for identifying risk of osteoarthritis and treatments thereof |
| 02/28/2007 | EP1756312A1 Genotyping of multiple loci with pcr for different loci amplification at different temperatures |
| 02/28/2007 | EP1756308A1 Compositions and methods for breast cancer prognosis |
| 02/28/2007 | EP1756159A1 C1q family member proteins with altered immunogenicity |
| 02/28/2007 | EP1756144A2 Isolated nucleic acid molecules encoding a novel phosphoprotein-darpp-32, encoded protein and uses thereof |
| 02/28/2007 | EP1756138A2 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |